Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.61
Delayed Data
As of Jul 31
 +0.28 / +2.27%
Today’s Change
9.51
Today|||52-Week Range
17.53
-18.65%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 17.00, with a high estimate of 19.00 and a low estimate of 13.00. The median estimate represents a +34.81% increase from the last price of 12.61.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.40
Sales
$21.5M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -260.57%
 
 
 
 
 
 
Growthannually -27.55%
 
 
 
 
 
 

Sales

Growthquarterly -80.25%
 
 
 
 
 
 
Growthannually 15.38%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.